Purpura fulminans due to Staphylococcus aureus

Clin Infect Dis. 2005 Apr 1;40(7):941-7. doi: 10.1086/428573. Epub 2005 Mar 2.

Abstract

Background: Purpura fulminans is an acute illness commonly associated with meningococcemia or invasive streptococcal disease, and it is typically characterized by disseminated intravascular coagulation (DIC) and purpuric skin lesions. In this article, we report the first 5 cases (to our knowledge) of purpura fulminans directly associated with Staphylococcus aureus strains that produce high levels of the superantigens toxic shock syndrome toxin-1 (TSST-1), staphylococcal enterotoxin serotype B (SEB), or staphylococcal enterotoxin serotype C (SEC).

Methods: Cases were identified in the Minneapolis-St. Paul, Minnesota, metropolitan area during 2000-2004. S. aureus infection was diagnosed on the basis of culture results, and susceptibility to methicillin was determined. The ability of the isolated organisms to produce TSST-1, SEB, SEC, and Panton-Valentine leukocidin (PVL) was determined. TSST-1, SEB, and SEC levels were also quantified after in vitro growth of the organisms.

Results: In 3 of the 5 cases, the infecting S. aureus strain was isolated from the blood cultures. In 2 of the 5 cases, the infecting S. aureus strain was isolated only from the respiratory tract, indicating that purpura fulminans and toxic shock syndrome resulted from exotoxin and/or other host factors, rather than septicemia. One of these latter 2 patients also had necrotizing pneumonia, and the isolated S. aureus was a methicillin-resistant strain that produced both SEC and PVL. Only 2 of the 5 patients survived, and 1 of the survivors received activated protein C.

Conclusions: Staphylococcal purpura fulminans may be a newly emerging illness associated with superantigen production. Medical practitioners should be aware of this illness.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Toxins / metabolism
  • Enterotoxins / metabolism
  • Exotoxins / metabolism
  • Female
  • Humans
  • Leukocidins
  • Male
  • Middle Aged
  • Purpura, Schoenlein-Henoch / etiology*
  • Purpura, Schoenlein-Henoch / microbiology
  • Purpura, Schoenlein-Henoch / pathology
  • Sepsis / complications
  • Sepsis / microbiology
  • Shock, Septic / etiology
  • Shock, Septic / pathology
  • Staphylococcal Infections / complications*
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology*
  • Staphylococcal Infections / pathology
  • Staphylococcus aureus / isolation & purification*
  • Staphylococcus aureus / metabolism
  • Superantigens / metabolism

Substances

  • Anti-Bacterial Agents
  • Bacterial Toxins
  • Enterotoxins
  • Exotoxins
  • Leukocidins
  • Panton-Valentine leukocidin
  • Superantigens
  • enterotoxin F, Staphylococcal
  • enterotoxin B, staphylococcal
  • enterotoxin C, staphylococcal